Clinical Trials Browser

Phase 1 × INDUSTRY × chiauranib × Clear all

NCT03216343 2023-08-30

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Phase 1 Completed

Small Cell Lung Carcinoma

NCT03074825 2019-07-24

Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma

Phase 1 Terminated

Lymphoma, Non-Hodgkin, Hereditary Sensory and Autonomic Neuropathies, Recurrence

NCT02122809 2016-06-17

Phase I Study of Chiauranib in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors